NCT00124514View on ClinicalTrials.gov

Triptorelin for Ovary Protection in Childhood Onset Lupus

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Triptorelin pamoate

IM injection given monthly

DRUG

Triptorelin Pamoate

IM injection given monthly

DRUG

Triptorelin Pamoate

IM injection given monthly

DRUG

Triptorelin Pamoate

IM injection given monthly

OTHER

placebo

placebo 0.9% normal saline IM injection

Trial Locations (10)

10032

Morgan Stanley Children's Hospital of New York, New York

43205

Columbus Children's Hospital, Columbus

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

53226

Children's Hospital of Wisconsin, Milwaukee

60614

Children's Memorial Hospital, Chicago

73104

Children's Hospital of Oklahoma, Oklahoma City

90027

Children's Hospital of Los Angeles, Los Angeles

98105

Seattle Children's Hospital, Seattle

07601

Hackensack University Medical Center, Hackensack

Unknown

University of Sao Paulo, São Paulo

Sponsors

Collaborators (1)

Watson Pharmaceuticals
All Listed Sponsors
collaborator

Watson Pharmaceuticals

INDUSTRY

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT00124514 - Triptorelin for Ovary Protection in Childhood Onset Lupus | Biotech Hunter | Biotech Hunter